CXS chemgenex pharmaceuticals ltd
Add to My Watchlist 0.00% ! 70.0¢

rbs rates chemgenex as buy

  1. diersel
    445 Posts.
    lightbulb Created with Sketch. 7
    clock Created with Sketch.
    30/10/10
    01:44
    Post #: 7408521
    RBS Australia rates Chemgenex (CXS.AX , 0.540, +0, +0%) as Upgrade to Buy from Hold (1) -ChemGenex has been carrying a short-term funding risk, the broker notes, ahead of product approval. But that problem has now been solved. US-based Cephalon Inc has taken $15m in convertibles worth a 9.6% stake on conversion, and separately agreed to buy a further 19.9% of stock from two major shareholders. Funding issue solved and a takeover on the cards. Upgrade to Buy. Target rises from 45c to 70c.

    - www.fnarena.com
    CXS Price at posting: 54.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS HotCopper Highlights: 4DS Memory's strategic review flags strategic review & more
right-arrow Created with Sketch.
NEWS Vulcan signs first major Phase One contract with NESI
right-arrow Created with Sketch.
NEWS Arrowsmith North Silica Sand Project granted works approval
right-arrow Created with Sketch.
AII Why Almonty Industries is THE tungsten mining stock to watch
right-arrow Created with Sketch.
MEM Memphasys secures transformational A$325K initial order with exclusive Middle East partnership
right-arrow Created with Sketch.
NEWS Rubix advances proposed acquisition of prospective Bauxite Projects in Africa
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.